Literature DB >> 31673311

Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents.

Franco Vairoletti1, Andrea Medeiros2,3, Pablo Fontán1, Jennifer Meléndrez1, Carlos Tabárez1, Gustavo Salinas4, Jaime Franco2, Marcelo A Comini2, Jenny Saldaña5, Vojtech Jancik6, Graciela Mahler1, Cecilia Saiz1.   

Abstract

1,4-Thiazepines derivatives are pharmacologically important heterocycles with different applications in medicinal chemistry. In the present work, we describe the preparation of new bicyclic thiazolidinyl-1,4-thiazepines 3 by reaction between azadithiane compounds and Michael acceptors. The reaction scope was explored and the yields were optimized. The activity of the new compounds was evaluated against Nippostrongylus brasiliensis and Caenorhabditis elegans as anthelmintic models and Trypanosoma brucei brucei. The most active compound was 3l, showing an EC50 = 2.8 ± 0.7 μM against T. b. brucei and a selectivity index >71. This journal is © The Royal Society of Chemistry 2019.

Entities:  

Year:  2019        PMID: 31673311      PMCID: PMC6786244          DOI: 10.1039/c9md00064j

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  26 in total

1.  Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.

Authors:  Warren R J D Galloway; Albert Isidro-Llobet; David R Spring
Journal:  Nat Commun       Date:  2010-09-21       Impact factor: 14.919

2.  Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.

Authors:  J A Robl; C Q Sun; J Stevenson; D E Ryono; L M Simpkins; M P Cimarusti; T Dejneka; W A Slusarchyk; S Chao; L Stratton; R N Misra; M S Bednarz; M M Asaad; H S Cheung; B E Abboa-Offei; P L Smith; P D Mathers; M Fox; T R Schaeffer; A A Seymour; N C Trippodo
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

3.  Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.

Authors:  Ricardo Augusto Massarico Serafim; José Eduardo Gonçalves; Felipe Pereira de Souza; Ana Paula de Melo Loureiro; Silvia Storpirtis; Renata Krogh; Adriano Defini Andricopulo; Luiz Carlos Dias; Elizabeth Igne Ferreira
Journal:  Eur J Med Chem       Date:  2014-06-03       Impact factor: 6.514

4.  Remarkable synthesis of 2-(Z)-6-(E)-4H-[1,4]-thiazepin-5-ones by zwitteronic rhodium-catalyzed chemo- and regioselective cyclohyrocarbonylative ring expansion of acetylenic thiazoles.

Authors:  B G Van den Hoven; H Alper
Journal:  J Am Chem Soc       Date:  2001-02-14       Impact factor: 15.419

5.  Thiazolothiazepine inhibitors of HIV-1 integrase.

Authors:  N Neamati; J A Turpin; H E Winslow; J L Christensen; K Williamson; A Orr; W G Rice; Y Pommier; A Garofalo; A Brizzi; G Campiani; I Fiorini; V Nacci
Journal:  J Med Chem       Date:  1999-08-26       Impact factor: 7.446

6.  Enantioselective synthesis of new oxazolidinylthiazolidines as enzyme inhibitors.

Authors:  Cecilia Saiz; Valentina Villamil; Mariano M González; Ma Agustina Rossi; Lorena Martínez; Leopoldo Suescun; Alejandro J Vila; Graciela Mahler
Journal:  Tetrahedron Asymmetry       Date:  2016-11-28

7.  Synthesis, pharmacological and antiviral activity of 1,3-thiazepine derivatives.

Authors:  Marta Struga; Jerzy Kossakowski; Anna E Koziol; Ewa Kedzierska; Sylwia Fidecka; Paolo La Colla; Cristina Ibba; Gabriella Collu; Giuseppina Sanna; Barbara Secci; Roberta Loddo
Journal:  Eur J Med Chem       Date:  2009-09-06       Impact factor: 6.514

8.  Discovering Echinococcus granulosus thioredoxin glutathione reductase inhibitors through site-specific dynamic combinatorial chemistry.

Authors:  Cecilia Saiz; Valerie Castillo; Pablo Fontán; Mariana Bonilla; Gustavo Salinas; Alejandra Rodríguez-Haralambides; S Graciela Mahler
Journal:  Mol Divers       Date:  2013-10-18       Impact factor: 2.943

9.  Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum.

Authors:  LiJun Song; JiaHuang Li; ShuYing Xie; ChunYan Qian; Jie Wang; Wei Zhang; Xuren Yin; ZiChun Hua; ChuanXin Yu
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

10.  Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates.

Authors:  Paola Hernández; Rosario Rojas; Robert H Gilman; Michel Sauvain; Lidia M Lima; Eliezer J Barreiro; Mercedes González; Hugo Cerecetto
Journal:  Eur J Med Chem       Date:  2012-11-07       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.